| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |